Benzaldehydes

• 

  Subject Areas on Research

  • A clinician's view of voxelotor. 
  • Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease. 
  • Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease. 
  • Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial. 
  • Copper complexes containing thiosemicarbazones derived from 6-nitropiperonal: Antimicrobial and biophysical properties. 
  • Darapladib for preventing ischemic events in stable coronary heart disease. 
  • Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease. 
  • Physical activity in patients with stable coronary heart disease: an international perspective. 
  • Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis. 
  • Retinoic acid-mediated gene expression in transgenic reporter zebrafish. 
  • Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease. 
  • Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. 
  • Solvation of acylium fragment ions in electrospray ionization quadrupole ion trap and Fourier transform ion cyclotron resonance mass spectrometry.